BFRG Logo

Bullfrog AI Holdings, Inc. Common Stock (BFRG) 

NASDAQ$1.8846-0.2 (-9.62%)
Market Cap
$19.58M
Sector
Healthcare
Industry
Medical—Healthcare Information Services
Rank in Sector
476 of 919
Rank in Industry
18 of 40

BFRG Insider Trading Activity

BFRG Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$00
Sells
$00

Related Transactions

No records found

About Bullfrog AI Holdings, Inc. Common Stock

BullFrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. It offers bfLEAP, an AI/ML platform for the analysis of preclinical and/or clinical data. The company also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of human cancer or neoplastic disease. BullFrog AI Holdings, Inc. was founded in 2017 and is based in Gaithersburg, Maryland.

Insider Activity of Bullfrog AI Holdings, Inc. Common Stock

Over the last 12 months, insiders at Bullfrog AI Holdings, Inc. Common Stock have bought $0 and sold $0 worth of Bullfrog AI Holdings, Inc. Common Stock stock.

On average, over the past 5 years, insiders at Bullfrog AI Holdings, Inc. Common Stock have bought $20,250 and sold $471,680 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 5,000 shares for transaction amount of $20,250 was made by Enright William (director) on 2023‑06‑14.

List of Insider Buy and Sell Transactions, Bullfrog AI Holdings, Inc. Common Stock

2024-01-22SaleSingh VininderChief Executive Officer
25,000
1.0009%
$7.50$187,500-60.21%
2024-01-17SaleSingh VininderChief Executive Officer
4,848
0.0824%
$3.18$15,440-15.99%
2024-01-16SaleSingh VininderChief Executive Officer
8,516
0.1161%
$2.55$21,741+1.70%
2024-01-12SaleSingh VininderChief Executive Officer
1,515
0.0207%
$2.56$3,873+5.08%
2024-01-11SaleSingh VininderChief Executive Officer
5,660
0.078%
$2.58$14,613+4.67%
2024-01-10SaleSingh VininderChief Executive Officer
4,780
0.0702%
$2.75$13,156-2.18%
2024-01-09SaleSingh VininderChief Executive Officer
3,144
0.0473%
$2.82$8,859-3.93%
2024-01-08SaleSingh VininderChief Executive Officer
5,184
0.0797%
$2.88$14,925-6.75%
2024-01-05SaleSingh VininderChief Executive Officer
2,644
0.0409%
$2.90$7,662-7.53%
2024-01-04SaleSingh VininderChief Executive Officer
3,569
0.0534%
$2.80$10,001-4.26%
2024-01-03SaleSingh VininderChief Executive Officer
5,676
0.0662%
$2.18$12,393-4.59%
2024-01-02SaleSingh VininderChief Executive Officer
4,464
0.0749%
$3.14$14,030-10.00%
2023-09-05SaleSingh VininderChief Executive Officer
50,000
0.7873%
$2.95$147,485-3.95%
2023-06-14PurchaseEnright Williamdirector
5,000
0.1081%
$4.05$20,250+41.86%
Total: 14

BFRG Institutional Investors: Active Positions

Increased Positions7+87.5%67,281+27.55%
Decreased Positions2-25%11,117-4.55%
New Positions4New53,766New
Sold Out Positions<1Sold Out10,317Sold Out
Total Postitions13+62.5%300,393+23%

BFRG Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Vanguard Group Inc$218.001.38%124,14700%2024-12-31
Fortem Financial Group, Llc$89.000.56%50,600-800-1.56%2024-12-31
Geode Capital Management, Llc$83.000.52%47,093+11,140+30.98%2024-12-31
Two Sigma Securities, Llc$36.000.23%20,701+20,701New2024-12-31
Ubs Group Ag$32.000.2%18,054+18,054New2024-12-31
Raymond James & Associates$26.000.17%15,00000%2024-09-30
Raymond James Financial Inc$26.000.17%15,000+15,000New2024-12-31
Morgan Stanley$11.000.07%6,47600%2024-12-31
Tower Research Capital Llc (Trc)$6.000.04%3,254+2,367+266.86%2024-12-31
Bank Of America Corp /De/$00%42+8+23.53%2024-12-31

Financial Ratios

Summary
Comparison with Competitors

Analyst Recommendations

No data is available at this moment.

Analyst Price Targets

No data is available at this moment.
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.